Mauerhan D R, Nelson C L, Smith D L, Fitzgerald R H, Slama T G, Petty R W, Jones R E, Evans R P
Department of Orthopedic Surgery, University of Arkansas for Medical Sciences, Little Rock 72201.
J Bone Joint Surg Am. 1994 Jan;76(1):39-45. doi: 10.2106/00004623-199401000-00006.
The efficacy of cefuroxime was compared with the efficacy of cefazolin for prophylaxis against postoperative wound infection in a prospective, double-blind, multicenter study of 1354 patients who had had elective primary or revision total hip or knee arthroplasty. The patients were randomly assigned to receive either 1.5 grams of cefuroxime followed by 750 milligrams eight and sixteen hours later (for a total of one day of antibiotic treatment), or one gram of cefazolin every eight hours for nine doses (for a total of three days of antibiotic treatment). The first dose of each drug was administered fifteen to sixty minutes before the operative incision was made (for a primary operation) or after tissue samples had been obtained for culture (for a revision procedure). After the operation, the patients were assessed daily while hospitalized and then at two to three months and one year after the operation. Demographic characteristics and risk factors were similar in the two groups. For the patients who had had a primary hip arthroplasty, the rate of deep wound infection was 0.5 per cent (one of 187) for those who had received cefuroxime and 1.2 per cent (two of 168) for those who had received cefazolin. For the patients who had had a primary knee arthroplasty, the rate of deep wound infection was 0.6 per cent (one of 178) for those who had received cefuroxime and 1.4 per cent (three of 207) for those who had received cefazolin.(ABSTRACT TRUNCATED AT 250 WORDS)
在一项针对1354例行择期初次或翻修全髋关节或膝关节置换术患者的前瞻性、双盲、多中心研究中,比较了头孢呋辛与头孢唑林预防术后伤口感染的疗效。患者被随机分配接受1.5克头孢呋辛,随后在8小时和16小时后各给予750毫克(共一天的抗生素治疗),或每8小时给予1克头孢唑林,共9剂(共三天的抗生素治疗)。每种药物的首剂在手术切口前15至60分钟(初次手术)或获取组织样本进行培养后(翻修手术)给药。术后,患者在住院期间每天接受评估,然后在术后两至三个月和一年进行评估。两组的人口统计学特征和危险因素相似。对于接受初次髋关节置换术的患者,接受头孢呋辛的患者深部伤口感染率为0.5%(187例中的1例),接受头孢唑林的患者为1.2%(168例中的2例)。对于接受初次膝关节置换术的患者,接受头孢呋辛的患者深部伤口感染率为0.6%(178例中的1例),接受头孢唑林的患者为1.4%(207例中的3例)。(摘要截取自250字)